Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report

Widysanto, Allen; Wahyuni, Titis Dewi; Simanjuntak, Leonardo; Sunarso, S.; Siahaan, Sylvia Sagita; Haryanto, Hori; Pandrya, C. O.; Aritonang, Ronald Christian Agustinus; Gunawan, C.; Angela, Angela

doi:10.1007/s11239-020-02338-7

Cited by 7 publications

(2 citation statements)

References 14 publications

(19 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…11 Cutaneous manifestations of COVID-19 include urticaria, 7 reticular rash, 12 red-purple papules, 13 urticarial and varicella-like exanthema, 14,15 petechiae, 16 and even ecchymosis. 17 Moreover, according to some authors, petechiae, purpura, and acral ischemia accompanied by coagulation disorders are prognostically unfavorable symptoms and may indicate a more severe course of the disease. 18 A clinical case of large vessel vasculitis after COVID-19 has been reported recently.…”

Section: Pathophysiologymentioning

confidence: 99%

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Messova¹,

Pivina²,

Muzdubayeva³

et al. 2022

Journal of Emergency Nursing

View full text Add to dashboard Cite

Section: Pathophysiologymentioning

confidence: 99%

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Messova¹,

Pivina²,

Muzdubayeva³

et al. 2022

Journal of Emergency Nursing

View full text Add to dashboard Cite

“…While DIC develops in only 0.6% of survivors, there is a 71.4% development rate in those who died of a COVID-19 infection (6). Previous studies have reported that pathologies, such as cutaneous involvement, vasculitis, livedo reticularis, and multiorgan failure, may be observed with the development of DIC in a COVID-19 infection (7,8).…”

Section: Introductionmentioning

confidence: 99%

Mortal disseminated intravascular coagulopathy and cutaneous involvement in a COVID-19 positive patient; case report

Bayrak

Çadırcı

2021

Anatolian Current Medical Journal

View full text Add to dashboard Cite

Coronavirus 2019 disease (COVID-19) is a highly deadly disease that hascaused 77 million cases and 1.6 million deaths worldwide. Many cutaneous manifestations are seen withCOVID-19. Cutaneous pathologies, such as vascular endothelial damage, prothrombotic conditions, haemorrhagic cutaneous lesions, vasculitis, disseminated intravascular coagulopathy (DIC), ecchymotic skin lesions, purpura and dry gangrene, are seen in patients with COVID-19. While our 84-year-old male patient was being treated for COVID-19-related pneumonia in the infection ward, DIC developed on the ninthday of his treatment and widespread petechia, purpura, ecchymosis, necrosis, gangrene and bullous skin lesions were observed onhis left arm related to this. Here, we aimed to present a case of DIC that developed as a complication of a COVID-19 infection and hada mortal course with cutaneous involvement, to the literature.

show abstract

Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review

Gisondi

Leo

Bellinato

et al. 2021

Dermatol Ther (Heidelb)

View full text Add to dashboard Cite

Introduction Distinct skin lesions associated with coronavirus disease 2019 (COVID-19) have been described, but data regarding their time of onset during the COVID-19 course are scant. Our objective was to systematically review the studies reporting the time of onset of selected skin lesions with respect to the reported onset of the COVID-19 core symptoms. Methods A comprehensive search of studies published before 21 January 2021 was performed on MEDLINE via PubMed database using a predefined strategy to identify relevant articles. Results Out of 354 references, 87 were selected, reporting a total of 895 patients with skin lesions associated with COVID-19. The most frequent pattern was exanthema ( n = 430, 48%), followed by vascular ( n = 299, 33%), urticarial ( n = 105, 12%) and others ( n = 66, 7%). Skin lesions occurred more frequently in the first 4 weeks from the COVID-19 onset ( n = 831, 92%), whereas prodromal or late lesions were rarer ( n = 69, 8%). The urticarial and exanthema patterns were more frequent in the first 2 weeks. About the vascular pattern some differences were noted among its subtypes. Livedoid lesions occurred mainly in the first 2 weeks, while chilblain-like lesions between weeks 2 and 4. Purpuric/petechial lesions were equally distributed during the first 4 weeks. Several skin manifestations did not fall into the pattern classification, including erythema multiforme, generalized pruritus, Kawasaki disease and others. Conclusion The diversity in the time of onset of skin lesions as well as their polymorphic nature likely reflects the diversity of the pathogenetic underlying mechanisms . PROSPERO database registration number CRD42021236331. Supplementary Information The online version contains supplementary material available at 10.1007/s13555-021-00526-8.

show abstract

Ecchymosis in critical coronavirus disease 2019 (COVID-19) patient in Tangerang, Indonesia: a case report

Cited by 7 publications

References 14 publications

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

COVID-19 and New Onset IgA Vasculitis: A Systematic Review of Case Reports

Mortal disseminated intravascular coagulopathy and cutaneous involvement in a COVID-19 positive patient; case report

Time of Onset of Selected Skin Lesions Associated with COVID-19: A Systematic Review

Contact Info

Product

Resources

About